Release Date: 28/08/15 16:15 Summary: Appendix 4G and Corporate Governance Statement Price Sensitive: No Download Document 359.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%